TREATMENT SET TS340074 injection, solution
TREATMENT SET TS340153 injection, solution
TREATMENT SET TS340525 injection, soluti United States - English - NLM (National Library of Medicine)

treatment set ts340074 injection, solution treatment set ts340153 injection, solution treatment set ts340525 injection, soluti

antigen laboratories, inc. - felis catus hair (unii: 1564hd0n96) (felis catus hair - unii:1564hd0n96), cynodon dactylon pollen (unii: 175f461w10) (cynodon dactylon pollen - unii:175f461w10), ambrosia artemisiifolia pollen (unii: k20y81aco3) (ambrosia artemisiifolia pollen - unii:k20y81aco3), carya alba pollen (unii: g2a764t54b) (carya tomentosa pollen - unii:g2a764t54b), dermatophagoides farinae (unii: pr9u2ypf3q) (dermatophagoides farinae - unii:pr9u2ypf3q), dermatophagoides pteronyssinus (unii: 57l1z5378k) (dermatophagoides pte - felis catus hair 400 [bau] in 1 ml - when the natural exposure to elevated aeroallergens produces symptoms as described under clinical pharmacology, specific diagnosis and therapeutic procedures are indicated. clearly, important clues to the cause of a person's allergic condition can be gleaned from a thorough history and careful physical examination. diagnostic tests - in vitro or in vivo - serve only to confirm the physician's suspicions or to improve investigative skills. specific diagnosis is especially indicated when the patient's symptoms are not controlled by medication. when immunotherapy is contemplated demonstration of sensitivity to a specific allergenic extract is necessary. an orderly approach to the use of diagnostic tests usually begins with direct skin testing. 5,6,11 this product is not intended for treatment of patients who do not manifest immediate hypersensitivity reactions to the allergenic extract following skin testing. there are no absolute contraindications; however, extreme caution is necessary when using diagnostic ski

TREATMENT SET TS336924 injection, solution
TREATMENT SET TS336312 injection, solution United States - English - NLM (National Library of Medicine)

treatment set ts336924 injection, solution treatment set ts336312 injection, solution

antigen laboratories, inc. - dermatophagoides pteronyssinus (unii: 57l1z5378k) (dermatophagoides pteronyssinus - unii:57l1z5378k), dermatophagoides farinae (unii: pr9u2ypf3q) (dermatophagoides farinae - unii:pr9u2ypf3q), penicillium chrysogenum var. chrysogenum (unii: 3y1pe1gcig) (penicillium chrysogenum var. chrysogenum - unii:3y1pe1gcig), cladosporium herbarum (unii: o64jf11198) (cladosporium herbarum - unii:o64jf11198), aspergillus fumigatus (unii: x88df51t48) (aspergillus fumigatus - unii:x88df51t48), alternaria alternata (uni - dermatophagoides pteronyssinus 400 [au] in 1 ml - when the natural exposure to elevated aeroallergens produces symptoms as described under clinical pharmacology, specific diagnosis and therapeutic procedures are indicated. clearly, important clues to the cause of a person's allergic condition can be gleaned from a thorough history and careful physical examination. diagnostic tests - in vitro or in vivo - serve only to confirm the physician's suspicions or to improve investigative skills. specific diagnosis is especially indicated when the patient's symptoms are not controlled by medication. when immunotherapy is contemplated demonstration of sensitivity to a specific allergenic extract is necessary. an orderly approach to the use of diagnostic tests usually begins with direct skin testing. 5,6,11 this product is not intended for treatment of patients who do not manifest immediate hypersensitivity reactions to the allergenic extract following skin testing. there are no absolute contraindications; however, extreme caution is necessary when using diagnostic ski

TREATMENT SET TS336667 injection, solution
TREATMENT SET TS336682 injection, solution
TREATMENT SET TS336683 injection, soluti United States - English - NLM (National Library of Medicine)

treatment set ts336667 injection, solution treatment set ts336682 injection, solution treatment set ts336683 injection, soluti

antigen laboratories, inc. - alternaria alternata (unii: 52b29rec7h) (alternaria alternata - unii:52b29rec7h), ambrosia artemisiifolia pollen (unii: k20y81aco3) (ambrosia artemisiifolia pollen - unii:k20y81aco3), felis catus hair (unii: 1564hd0n96) (felis catus hair - unii:1564hd0n96), canis lupus familiaris hair (unii: 05s7l91ztr) (canis lupus familiaris hair - unii:05s7l91ztr), phleum pratense pollen (unii: 65m88rw2eg) (phleum pratense pollen - unii:65m88rw2eg) - alternaria alternata 0.002 g in 1 ml - when the natural exposure to elevated aeroallergens produces symptoms as described under clinical pharmacology, specific diagnosis and therapeutic procedures are indicated. clearly, important clues to the cause of a person's allergic condition can be gleaned from a thorough history and careful physical examination. diagnostic tests - in vitro or in vivo - serve only to confirm the physician's suspicions or to improve investigative skills. specific diagnosis is especially indicated when the patient's symptoms are not controlled by medication. when immunotherapy is contemplated demonstration of sensitivity to a specific allergenic extract is necessary. an orderly approach to the use of diagnostic tests usually begins with direct skin testing. 5,6,11 this product is not intended for treatment of patients who do not manifest immediate hypersensitivity reactions to the allergenic extract following skin testing. there are no absolute contraindications; however, extreme caution is necessary when using diagnostic ski

TREATMENT SET TS337026 injection, solution
TREATMENT SET TS336851 injection, solution United States - English - NLM (National Library of Medicine)

treatment set ts337026 injection, solution treatment set ts336851 injection, solution

antigen laboratories, inc. - canis lupus familiaris hair (unii: 05s7l91ztr) (canis lupus familiaris hair - unii:05s7l91ztr), dermatophagoides farinae (unii: pr9u2ypf3q) (dermatophagoides farinae - unii:pr9u2ypf3q), ambrosia artemisiifolia pollen (unii: k20y81aco3) (ambrosia artemisiifolia pollen - unii:k20y81aco3), ambrosia trifida pollen (unii: ku1v1898xx) (ambrosia trifida pollen - unii:ku1v1898xx), ambrosia psilostachya pollen (unii: rx18m46k8l) (ambrosia psilostachya pollen - unii:rx18m46k8l), gallus gallus feather (unii: 1fcm - canis lupus familiaris hair 0.002 g in 1 ml - when the natural exposure to elevated aeroallergens produces symptoms as described under clinical pharmacology, specific diagnosis and therapeutic procedures are indicated. clearly, important clues to the cause of a person's allergic condition can be gleaned from a thorough history and careful physical examination. diagnostic tests - in vitro or in vivo - serve only to confirm the physician's suspicions or to improve investigative skills. specific diagnosis is especially indicated when the patient's symptoms are not controlled by medication. when immunotherapy is contemplated demonstration of sensitivity to a specific allergenic extract is necessary. an orderly approach to the use of diagnostic tests usually begins with direct skin testing. 5,6,11 this product is not intended for treatment of patients who do not manifest immediate hypersensitivity reactions to the allergenic extract following skin testing. there are no absolute contraindications; however, extreme caution is necessary when using diagnostic ski

TREATMENT SET TS338618 injection, solution
TREATMENT SET TS338909 injection, solution
TREATMENT SET TS338910 injection, soluti United States - English - NLM (National Library of Medicine)

treatment set ts338618 injection, solution treatment set ts338909 injection, solution treatment set ts338910 injection, soluti

antigen laboratories, inc. - felis catus hair (unii: 1564hd0n96) (felis catus hair - unii:1564hd0n96), cynodon dactylon pollen (unii: 175f461w10) (cynodon dactylon pollen - unii:175f461w10), phleum pratense pollen (unii: 65m88rw2eg) (phleum pratense pollen - unii:65m88rw2eg), ambrosia artemisiifolia pollen (unii: k20y81aco3) (ambrosia artemisiifolia pollen - unii:k20y81aco3), iva annua var. annua pollen (unii: y2u5s5pf22) (iva annua var. annua pollen - unii:y2u5s5pf22), fraxinus americana pollen (unii: g684lx721q) (fraxinus ameri - felis catus hair 2000 [bau] in 1 ml - when the natural exposure to elevated aeroallergens produces symptoms as described under clinical pharmacology, specific diagnosis and therapeutic procedures are indicated. clearly, important clues to the cause of a person's allergic condition can be gleaned from a thorough history and careful physical examination. diagnostic tests - in vitro or in vivo - serve only to confirm the physician's suspicions or to improve investigative skills. specific diagnosis is especially indicated when the patient's symptoms are not controlled by medication. when immunotherapy is contemplated demonstration of sensitivity to a specific allergenic extract is necessary. an orderly approach to the use of diagnostic tests usually begins with direct skin testing. 5,6,11 this product is not intended for treatment of patients who do not manifest immediate hypersensitivity reactions to the allergenic extract following skin testing. there are no absolute contraindications; however, extreme caution is necessary when using diagnostic ski

TREATMENT SET TS335823 injection, solution
TREATMENT SET TS335861 injection, solution United States - English - NLM (National Library of Medicine)

treatment set ts335823 injection, solution treatment set ts335861 injection, solution

antigen laboratories, inc. - poa pratensis pollen (unii: scb8j7ls3t) (poa pratensis pollen - unii:scb8j7ls3t), dermatophagoides farinae (unii: pr9u2ypf3q) (dermatophagoides farinae - unii:pr9u2ypf3q), alternaria alternata (unii: 52b29rec7h) (alternaria alternata - unii:52b29rec7h), ambrosia trifida pollen (unii: ku1v1898xx) (ambrosia trifida pollen - unii:ku1v1898xx), ambrosia artemisiifolia pollen (unii: k20y81aco3) (ambrosia artemisiifolia pollen - unii:k20y81aco3), ambrosia psilostachya pollen (unii: rx18m46k8l) (ambrosia psil - poa pratensis pollen 160 [bau] in 1 ml - when the natural exposure to elevated aeroallergens produces symptoms as described under clinical pharmacology, specific diagnosis and therapeutic procedures are indicated. clearly, important clues to the cause of a person's allergic condition can be gleaned from a thorough history and careful physical examination. diagnostic tests - in vitro or in vivo - serve only to confirm the physician's suspicions or to improve investigative skills. specific diagnosis is especially indicated when the patient's symptoms are not controlled by medication. when immunotherapy is contemplated demonstration of sensitivity to a specific allergenic extract is necessary. an orderly approach to the use of diagnostic tests usually begins with direct skin testing. 5,6,11 this product is not intended for treatment of patients who do not manifest immediate hypersensitivity reactions to the allergenic extract following skin testing. there are no absolute contraindications; however, extreme caution is necessary when using diagnostic ski

TREATMENT SET TS344558 injection, solution
TREATMENT SET TS344570 injection, solution United States - English - NLM (National Library of Medicine)

treatment set ts344558 injection, solution treatment set ts344570 injection, solution

antigen laboratories, inc. - cladosporium cladosporioides (unii: 4zwy20gtgo) (cladosporium cladosporioides - unii:4zwy20gtgo), aspergillus fumigatus (unii: x88df51t48) (aspergillus fumigatus - unii:x88df51t48), cochliobolus sativus (unii: 3ln5b70u4w) (cochliobolus sativus - unii:3ln5b70u4w), aureobasidium pullulans var. pullutans (unii: d1a2ng69ck) (aureobasidium pullulans var. pullutans - unii:d1a2ng69ck), fusarium oxysporum (unii: 5398rxp8ku) (fusarium oxysporum - unii:5398rxp8ku), penicillium chrysogenum var. chrysogenum (unii: - cladosporium cladosporioides 0.00008 g in 1 ml - when the natural exposure to elevated aeroallergens produces symptoms as described under clinical pharmacology, specific diagnosis and therapeutic procedures are indicated. clearly, important clues to the cause of a person's allergic condition can be gleaned from a thorough history and careful physical examination. diagnostic tests - in vitro or in vivo - serve only to confirm the physician's suspicions or to improve investigative skills. specific diagnosis is especially indicated when the patient's symptoms are not controlled by medication. when immunotherapy is contemplated demonstration of sensitivity to a specific allergenic extract is necessary. an orderly approach to the use of diagnostic tests usually begins with direct skin testing. 5,6,11 this product is not intended for treatment of patients who do not manifest immediate hypersensitivity reactions to the allergenic extract following skin testing. there are no absolute contraindications; however, extreme caution is necessary when using diagnostic ski

ALLERGENIC EXTRACTSINDIVIDUAL TREATMENT VIAL United States - English - NLM (National Library of Medicine)

allergenic extractsindividual treatment vial

antigen laboratories, inc. - ambrosia artemisiifolia pollen (unii: k20y81aco3) (ambrosia artemisiifolia pollen - unii:k20y81aco3), cynodon dactylon pollen (unii: 175f461w10) (cynodon dactylon pollen - unii:175f461w10), poa pratensis pollen (unii: scb8j7ls3t) (poa pratensis pollen - unii:scb8j7ls3t), sorghum halepense pollen (unii: 577va5b4hp) (sorghum halepense pollen - unii:577va5b4hp), quercus alba pollen (unii: z4y9zsv4kk) (quercus alba pollen - unii:z4y9zsv4kk), carya alba pollen (unii: g2a764t54b) (carya alba pollen - unii:g - ambrosia artemisiifolia pollen 10000 [au] in 1 ml - when the natural exposure to elevated aeroallergens produces symptoms as described under clinical pharmacology, specific diagnosis and therapeutic procedures are indicated. clearly, important clues to the cause of a person's allergic condition can be gleaned from a thorough history and careful physical examination. diagnostic tests - in vitro or in vivo - serve only to confirm the physician's suspicions or to improve investigative skills. specific diagnosis is especially indicated when the patient's symptoms are not controlled by medication. when immunotherapy is contemplated demonstration of sensitivity to a specific allergenic extract is necessary. an orderly approach to the use of diagnostic tests usually begins with direct skin testing. 5,6,11 this product is not intended for treatment of patients who do not manifest immediate hypersensitivity reactions to the allergenic extract following skin testing. there are no absolute contraindications; however, extreme caution is necessary when using diagnostic ski

TREATMENT SET TS332256 injection, solution
TREATMENT SET TS331153 injection, solution
TREATMENT SET TS329151 injection, soluti United States - English - NLM (National Library of Medicine)

treatment set ts332256 injection, solution treatment set ts331153 injection, solution treatment set ts329151 injection, soluti

antigen laboratories, inc. - quercus alba pollen (unii: z4y9zsv4kk) (quercus alba pollen - unii:z4y9zsv4kk), ulmus americana pollen (unii: 89bat511bd) (ulmus americana pollen - unii:89bat511bd), cynodon dactylon pollen (unii: 175f461w10) (cynodon dactylon pollen - unii:175f461w10), phleum pratense pollen (unii: 65m88rw2eg) (phleum pratense pollen - unii:65m88rw2eg), acer negundo pollen (unii: p6k070ar8v) (acer negundo pollen - unii:p6k070ar8v), juniperus ashei pollen (unii: 544f8mey0y) (juniperus ashei pollen - unii:544f8mey0y), - quercus alba pollen 0.00167 g in 1 ml - when the natural exposure to elevated aeroallergens produces symptoms as described under clinical pharmacology, specific diagnosis and therapeutic procedures are indicated. clearly, important clues to the cause of a person's allergic condition can be gleaned from a thorough history and careful physical examination. diagnostic tests - in vitro or in vivo - serve only to confirm the physician's suspicions or to improve investigative skills. specific diagnosis is especially indicated when the patient's symptoms are not controlled by medication. when immunotherapy is contemplated demonstration of sensitivity to a specific allergenic extract is necessary. an orderly approach to the use of diagnostic tests usually begins with direct skin testing. 5,6,11 this product is not intended for treatment of patients who do not manifest immediate hypersensitivity reactions to the allergenic extract following skin testing. there are no absolute contraindications; however, extreme caution is necessary when using diagnostic ski

TREATMENT SET TS344592 injection, solution
TREATMENT SET TS344801 injection, solution
TREATMENT SET TS345048 injection, soluti United States - English - NLM (National Library of Medicine)

treatment set ts344592 injection, solution treatment set ts344801 injection, solution treatment set ts345048 injection, soluti

antigen laboratories, inc. - dermatophagoides pteronyssinus (unii: 57l1z5378k) (dermatophagoides pteronyssinus - unii:57l1z5378k), canis lupus familiaris hair (unii: 05s7l91ztr) (canis lupus familiaris hair - unii:05s7l91ztr) - dermatophagoides pteronyssinus 2000 [au] in 1 ml - when the natural exposure to elevated aeroallergens produces symptoms as described under clinical pharmacology, specific diagnosis and therapeutic procedures are indicated. clearly, important clues to the cause of a person's allergic condition can be gleaned from a thorough history and careful physical examination. diagnostic tests - in vitro or in vivo - serve only to confirm the physician's suspicions or to improve investigative skills. specific diagnosis is especially indicated when the patient's symptoms are not controlled by medication. when immunotherapy is contemplated demonstration of sensitivity to a specific allergenic extract is necessary. an orderly approach to the use of diagnostic tests usually begins with direct skin testing. 5,6,11 this product is not intended for treatment of patients who do not manifest immediate hypersensitivity reactions to the allergenic extract following skin testing. there are no absolute contraindications; however, extreme caution is necessary when using diagnostic ski